| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/12/2009 | EP2087007A2 Agonist trkb antibodies and uses thereof |
| 08/12/2009 | EP2086991A1 CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 08/12/2009 | EP2086975A2 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 08/12/2009 | EP2086970A2 2-(pyrazin-2-yl)-thiazole and 2-(1h pyrazol-3-yl)-thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 08/12/2009 | EP2086964A2 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk |
| 08/12/2009 | EP2086951A1 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
| 08/12/2009 | EP2086943A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 08/12/2009 | EP2086933A2 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/12/2009 | EP2086532A1 Use for treating obesity and diabetes |
| 08/12/2009 | EP2086353A1 Nutritional products comprising saccharide oligomers |
| 08/12/2009 | EP1819681B1 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
| 08/12/2009 | EP1756096B1 Indolyl derivatives as liver-x-receptor modulators |
| 08/12/2009 | EP1631291B1 Use of tyrosine kinase inhibitors to treat diabetes |
| 08/12/2009 | EP1601346B1 Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method |
| 08/12/2009 | EP1515959B1 Pharmaceutical salts of reboxetine |
| 08/12/2009 | EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 08/12/2009 | EP1274319B1 Compositions and methods for improving vascular health |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | CN101506210A 2-phenoxy pyrimidinone analogues |
| 08/12/2009 | CN101506203A 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and o |
| 08/12/2009 | CN101506158A Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 08/12/2009 | CN101506138A Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 08/12/2009 | CN101505778A Hypoglycemic composition containing component originating in the bark of tree belonging to the genus acacia |
| 08/12/2009 | CN101505776A Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
| 08/12/2009 | CN101505771A Processes for production of HOODIA plant extracts containing steroidal glycosides |
| 08/12/2009 | CN101505764A Drug composition for treating 2 type diabetes and its chronicity neopathy |
| 08/12/2009 | CN101505733A Active agent formulations, methods of making, and methods of use |
| 08/12/2009 | CN101503454A Compound for preparing cholic acid conjugate, preparation and use thereof |
| 08/12/2009 | CN101503409A 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments |
| 08/12/2009 | CN101503408A 8-(3-amino-piperidin-1-yl)-xanthines |
| 08/12/2009 | CN101503399A C-aryl glucoside SGLT2 inhibitor |
| 08/12/2009 | CN101503365A Preparation of venlafaxine intermediate 1-[2-amino-1-(4-methoxy phenyl)ethyl] cyclohexanol |
| 08/12/2009 | CN101503356A Novel method for preparing high-purity chlorogenic acid |
| 08/12/2009 | CN101502646A Preparation for female body shaping and gynaecological inflammation and method for producing the same |
| 08/12/2009 | CN101502640A Compound dipeptide pharmaceutical formulations and preparation method thereof |
| 08/12/2009 | CN101502639A Glycyl-L-tyrosine pharmaceutical formulations and preparation method thereof |
| 08/12/2009 | CN101502638A Glycyl-L-glutamine pharmaceutical formulation and preparation method thereof |
| 08/12/2009 | CN101502621A Nutrient solution for cleaning blood and softening blood vessel |
| 08/12/2009 | CN101502620A Pure natural concentrated health-care capsule for protecting liver, expelling toxin and lowering lipid |
| 08/12/2009 | CN101502613A Body-strengthening fatigue-resisting lipid-lowering oral liquid and capsule |
| 08/12/2009 | CN101502600A Chinese medicinal composition for reducing blood fat and preparation method thereof |
| 08/12/2009 | CN101502591A Pharmaceutical composition for reducing blood sugar and blood fat |
| 08/12/2009 | CN101502590A Pharmaceutical composition for reducing blood sugar and blood fat |
| 08/12/2009 | CN101502585A Chinese red pepper plant extract as well as preparation method and application thereof |
| 08/12/2009 | CN101502559A Method for continuously extracting effective ingredients from Semen cassiae under high pressure |
| 08/12/2009 | CN101502541A Styrax plant and use of extract thereof |
| 08/12/2009 | CN101502539A Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation |
| 08/12/2009 | CN101502536A Cedar total flavone as well as preparation method and medical use |
| 08/12/2009 | CN101502529A Application of vincetoxicoside B in preparing antidiabetic medicament |
| 08/12/2009 | CN101502518A Glipizide sustained-release granular formulation and preparation method thereof |
| 08/12/2009 | CN101502517A Glipizide enteric sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502507A Egonol type benzofuran and novel use in pharmacy of glycosides thereof |
| 08/12/2009 | CN101502497A Fenofibrate medicament composition |
| 08/12/2009 | CN101502489A Intestinal nutrient solution with special medical goal |
| 08/12/2009 | CN101502327A Method for biological selenium compensation and promotion of upgrowth and development of children |
| 08/12/2009 | CN101502323A Elemental diet suitable for severe patient and patient with metabolic intestinal dysfunction as well as preparation method thereof |
| 08/12/2009 | CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 08/12/2009 | CN100525825C 'Naoxinan' tablet in use for cardiovascular disease, cerebrovascular disease and preparation method |
| 08/12/2009 | CN100525804C Chinese traditional medicine compound preparations having a function of slimming |
| 08/12/2009 | CN100525791C Health product and medicine and their preparing method |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/12/2009 | CN100525762C Formula of essential amino acids oral-liquor and its preparation method |
| 08/12/2009 | CN100525757C Resolution of alpha-(phenoxy)phenylacetic acid derivatives |
| 08/12/2009 | CN100525754C Compound preparation for lowering blood-sugar |
| 08/12/2009 | CN100525753C Submicron emulsion injection liquid of CoQ10 and preparation process thereof |
| 08/12/2009 | CN100525654C Applacation of combination for preparation of beverage containing all kinds of essential fatty-acid and essential amino-cid |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572920 Benzimidazole derivative and use as a II receptor antagonist |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572815 Amide derivative |
| 08/11/2009 | US7572801 Pyridopyrimidinone derivatives which are HM74A agonists |
| 08/11/2009 | US7572799 Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
| 08/11/2009 | US7572770 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 08/11/2009 | US7572763 Controlling cell differentiation; muscular disorders |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | US7572470 Licorice extract for use as a medicament |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | CA2527933C Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 08/11/2009 | CA2487033C Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2470581C Antidiabetic formulation and method |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2422699C Compositions for treating diabetes |
| 08/11/2009 | CA2417590C Prophylactic or ameliorative agent for insulin resistance and/or obesity |
| 08/11/2009 | CA2391539C Use of poly(diallylamine) polymers |
| 08/11/2009 | CA2381339C Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
| 08/11/2009 | CA2375378C Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines |
| 08/11/2009 | CA2331393C Fatty acid analogues for the treatment of primary and secondary restenosis |
| 08/11/2009 | CA2258503C Lectin compositions and uses thereof |
| 08/06/2009 | WO2009097443A2 Liquid formulations of compounds active at sulfonylurea receptors |
| 08/06/2009 | WO2009097416A1 Imidazolylalkyl- pyridines as dbh inhibitors |